Concurrent chemoradiotherapy for locally advanced unresectable adenoid cystic carcinoma of head and neck: experience from a single institute
Monali Swain(Tata Memorial Hospital), Jai Prakash Agarwal(Tata Memorial Hospital), Vedang Murthy(Homi Bhabha National Institute), Amit Joshi(Dr. Rajendra Prasad Government Medical College), Vanita Naronha(Homi Bhabha National Institute), Sarbani Ghosh‐Laskar(Tata Memorial Hospital), Ashwini Budrukkar(Tata Memorial Hospital), Kumar Prabhash(Homi Bhabha National Institute), Roshan Patil(Homi Bhabha National Institute), Tejpal Gupta(Tata Memorial Hospital), Vijay Patil(Homi Bhabha National Institute), Naveen Mummudi(Homi Bhabha National Institute)
Cited by 14
Related Papers
The Lancet Commission on prostate cancer: planning for the surge in cases
|The Lancet|2024|694
Management of Patients with Advanced Prostate Cancer: The Report of the Advanced Prostate Cancer Consensus Conference APCCC 2017
|European Urology|2017|644
Management of Patients with Advanced Prostate Cancer: Report of the Advanced Prostate Cancer Consensus Conference 2019
|European Urology|2020|396
Diagnostic performance of post-treatment FDG PET or FDG PET/CT imaging in head and neck cancer: a systematic review and meta-analysis
|European Journal of Nuclear Medicine and Molecular Imaging|2011|377
Once-a-Week Versus Once-Every-3-Weeks Cisplatin Chemoradiation for Locally Advanced Head and Neck Cancer: A Phase III Randomized Noninferiority Trial
|Journal of Clinical Oncology|2017|340